Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleRegarding "Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies".AuthorsChabner, Bruce A.AbstractThis editorial reflects on improvements in the cancer drug approval process of the U.S. Food and Drug Administration.SubjectsDRUG approval; ANTINEOPLASTIC agents; CLINICAL trials; ONCOLOGY; PATIENT safety; UNITED States. Food &; Drug Administration; DRUG development; GOVERNMENT policy; STANDARDSPublicationOncologist, 2017, Vol 22, Issue 7, p757ISSN1083-7159Publication typeEditorialDOI10.1634/theoncologist.2017-0202